“…Additionally, the clinical profiles (comorbidity types, clinical complication types, anatomical site of infection, diagnostic methods, drug resistance profiles, HIV serostatus, treatment outcomes and definition of anemia) of DR-TB patients per individual study were assessed and we summarized this in detail in Table 2. Among all 17 studies, 12 (Alene et al, 2017;Woldeyohannes et al, 2019;Meressa et al, 2015;Getachew et al, 2013;Girum et al, 2017;Shimbre et al, 2020;Gebre et al, 2020;Fantaw et al, 2018;Molalign and Wencheko, 2015;Woya et al, 2019;Abebe et al, 2020;Baye et al, 2018) and 15 (Ketema et al, 2019;Molie et al, 2019;Alene et al, 2017;Limenih and Workie, 2019;Woldeyohannes et al, 2019;Meressa et al, 2015;Getachew et al, 2013;Girum et al, 2017;Shimbre et al, 2020;Gebre et al, 2020;Fantaw et al, 2018;Molalign and Wencheko, 2015;Woya et al, 2019;Abebe et al, 2020;Baye et al, 2018) studies explored mortality and poor treatment outcomes, respectively. The incidence density rate of poor treatment outcome and mortality using the time to an event (poor treatment outcome or mortality) were explored by 12 (Ketema et al, 2019;Alene et al, 2017;Limenih and Workie, 2019;Woldeyohannes et al, 2019;Getachew et al, 2013;Girum et al, 2017;Shimbre et al, 2020;Gebre et al, 2020;Fantaw et al, 2018;<...>…”